Apatinib in Combination With Stereotactic Body Radiation Therapy (SBRT) Treatment for Symptomatic Metastatic Prostate Cancer

NCT02998242 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Quality of Life

Interventions

DRUG: Apatinib
RADIATION: SBRT to symptomatic bony metastatic bony site(s)

Sponsor

Sichuan Provincial People's Hospital

Collaborators

[object Object]
[object Object]